下一代基于抗体的癌症治疗:抗体-药物偶联物和双特异性抗体在血液系统恶性肿瘤和实体瘤中的应用
Next-generation antibody-based therapeutics in cancer: antibody-drug conjugates bispecific antibodies across hematologic malignancies and solid tumors
肿瘤学的治疗范式正在经历由抗体药物偶联物(ADC)和双特异性抗体(bsAb)驱动的深刻变革。
ALL SOURCES
Next-generation antibody-based therapeutics in cancer: antibody-drug conjugates bispecific antibodies across hematologic malignancies and solid tumors
肿瘤学的治疗范式正在经历由抗体药物偶联物(ADC)和双特异性抗体(bsAb)驱动的深刻变革。
Sequential CAR T cell and targeted alpha immunotherapy in disseminated multiple myeloma.
TAT(7.4 kBq)后序贯 CAR T 治疗,在 TAT 后延迟 21 天对比 14 天或 28 天进行 CAR T 治疗时也有效,突显了序贯治疗时机的重要性。
Review of Adoptive Cellular Therapies for the Treatment of Sarcoma.
肉瘤是一组异质性恶性肿瘤,治疗选择有限,尤其是在转移性情况下。
An In Silico Approach to Uncover Selective JAK1 Inhibitors for Breast Cancer from Life Chemicals Database.
JAK1是多种致癌通路的关键调控因子,是一个备受关注的靶点,其在免疫细胞和TIL(肿瘤浸润淋巴细胞)(TILs)中的表达与乳腺癌的良好预后相关。
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。